Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laredo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Anesthesia and Analgesia|December 1, 1985
Epidural ketamine for control of postoperative painJ A Islas, J Astorga, M Laredo
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1997
Citicoline improves memory performance in elderly subjectsX A Alvarez, M Laredo, D Corzo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 24, 2001
Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamicsX A Alvarez, V Pichel, P Pérez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 12, 2000
Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusionX A Alvarez, R Mouzo, V Pichel, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjectsX A Alvarez, V R Lombardi, L Corzo, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomicsR Cacabelos, A Alvarez, V Lombardi, et al.
European Journal of Neurology|January 20, 2006
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's diseaseX A Alvarez, R Cacabelos, M Laredo, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1991
[Acetylation polymorphism in lung cancer]J M Laredo Quesada, C Jara Sánchez, J Benítez Rodríguez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anesthesia and Analgesia|December 1, 1985
Epidural ketamine for control of postoperative painJ A Islas, J Astorga, M Laredo
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1997
Citicoline improves memory performance in elderly subjectsX A Alvarez, M Laredo, D Corzo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 24, 2001
Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamicsX A Alvarez, V Pichel, P Pérez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 12, 2000
Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusionX A Alvarez, R Mouzo, V Pichel, et al.
Journal of Neural Transmission. Supplementum|August 29, 2000
Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjectsX A Alvarez, V R Lombardi, L Corzo, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomicsR Cacabelos, A Alvarez, V Lombardi, et al.
European Journal of Neurology|January 20, 2006
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's diseaseX A Alvarez, R Cacabelos, M Laredo, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1991
[Acetylation polymorphism in lung cancer]J M Laredo Quesada, C Jara Sánchez, J Benítez Rodríguez, et al.
Pageof 1